Loading provider…
Loading provider…
Cardiovascular Disease Physician in Derby, CT
NPI: 1073560736Primary Practice Location
GRIFFIN HOSPITAL
220 Main St, Oxford, CT
Primary Employer
Heart Specialists of Sarasota PL
heartspecialistsofsarasota.com
HQ Phone
Get MD Anthony's Phone Numberphone_androidMobile
Get MD Anthony's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
NY State Medical License
1979
FL State Medical License
2004 - 2027
CT State Medical License
1981 - 2026
PA State Medical License
1978 - 1978

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease
Bridgeport Hospital/Yale University
Fellowship • Cardiovascular Disease
1981 - 1984
Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)
Residency • Internal Medicine
1978 - 1981
St Luke’s Hospital – Anderson Campus
Internship • Transitional Year
1977 - 1978
Lokmanya Tilak Municipal Medical College
ltmgh.com
Medical School
Until 1977
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 260 | 294 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 221 | 261 |
| 3 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 127 | 134 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 89 | 128 |
| 5 | 93015Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 62 | 63 |
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.
Authors: Uy, G. L., Costa, L. J., Hari, P. N., Zhang, M. J., Huang, J. X., Anderson, K. C., Bredeson, C. N., Callander, N. S., Cornell, R. F., Perez, M. A., Dispenzieri, A., Freytes, C. O., Gale, R. P., Garfall, A., Gertz, M. A., Gibson, J., Hamadani, M., Lazarus, H. M., Kalaycio, M. E., Kamble, R. T., Kharfan-Dabaja, M. A., Krishnan, A. Y., Kumar, S. K., Kyle, R. A., Landau, H. J., Lee, C. H., Maiolino, A., Marks, D. I., Mark, T. M., Munker, R., Nishihori, T., Olsson, R. F., Ramanathan, M., Rodriguez, T. E., Saad, A. A., Savani, B. N., Schiller, G. J., Schouten, H. C., Schriber, J. R., Scott, E., Seo, S., Sharma, M., Ganguly, S., Stadtmauer, E. A., Tay, J., To, L. B., Vesole, D. H., Vogl, D. T., Wagner, J. L., Wirk, B., Wood, W. A., D'Souza, A.